A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a ...

MORE: Pediatric pneumonia cases are on the rise. Here's what parents should know Just a few months after Schmidtknecht's death, the makers of Advair, GSK, announced in March 2024 that starting ...

Just a few months after Schmidtknecht’s death, the makers of Advair, GSK ... Jade Cobern, MD, MPH, who is board-certified in pediatrics and general preventive medicine, recommended individuals ...

Just a few months after Schmidtknecht's death, the makers of Advair, GSK, announced in March ... Jade Cobern, MD, MPH, who is board-certified in pediatrics and general preventive medicine ...

After topping the Street's expectations with its Q3 earnings, Cipla announced plans to launch two key drugs in FY26—the respiratory drug Advair and the oncology drug Abraxane. Umang Vohra ...

21 in Wisconsin federal court. Schmidtknecht took daily doses of Advair Diskus to manage his asthma, the lawsuit said. His medication was covered by his employer-provided health insurance United ...

Pediatric stroke is a rare condition affecting one in every 4,000 newborns and an additional 2,000 older children each year. Stroke, sometimes known as a cerebrovascular accident (CVA), is much more ...

While Sandoz has emerged as the front-runner to get a generic version of GlaxoSmithKline’s respiratory blockbuster Advair to the US market, rival Hikma has not given up despite a major setback.

GlaxoSmithKline’s ageing respiratory blockbuster Advair has been living a charmed life since going off patent years ago - but as yet no-one has been able to get a generic rival approved in the ...